Automated tryptic digestion procedure for HPLC/MS/MS peptide mapping of immunoglobulin gamma antibodies in pharmaceutics.

The rapid growth of antibody drugs and drug candidates in the biopharmaceutical industry has created a demand for automated proteolytic digestion to assist in pharmaceutical stability studies, identity assays and quality control of these therapeutic proteins. Here, we describe the development of a fully automated proteolytic digestion procedure for monoclonal antibodies in solution, which requires a high concentration of denaturants for unfolding. The antibody samples were placed in a 96-well plate or in 0.5-mL Eppendorf tubes. The proteins were then reduced and alkylated in a denaturing solution of 6M guanidine HCl. The denaturing solution was replaced with a digestion buffer using a custom-designed 96-well size-exclusion plate for desalting. The sample was digested for 5 h with two additions of trypsin. The completeness and reproducibility of digestion were verified by reversed-phase high-performance liquid chromatography tandem mass spectrometry (HPLC/MS) analysis of the digestion products. The performance of the automatic digestion was comparable to the currently used manual digestion procedure, but saved time, reduced manual labor, and increased the reproducibility of the tryptic digests. Our method should be useful not only for high-throughput analysis of antibodies, but for other therapeutic protein samples as well. Other applications like gel-free proteomics, where the analysis of a large number of samples is often needed and the completeness of the liquid digestion is critical for the identification of a large number of different proteins, should also benefit from this fully automated liquid proteolytic digestion procedure.

[1]  W. Hancock,et al.  Characterization of humanized anti-TAC, an antibody directed against the interleukin 2 receptor, using electrospray ionization mass spectrometry by direct infusion, LC/MS, and MS/MS. , 1994, Analytical chemistry.

[2]  Jinsam You,et al.  A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis. , 2004, Analytical biochemistry.

[3]  Thomas Hartmann,et al.  Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. , 2004, Cancer cell.

[4]  Zhongqi Zhang Prediction of low-energy collision-induced dissociation spectra of peptides. , 2004, Analytical chemistry.

[5]  M. Mulkerrin,et al.  Rapid analytical tryptic mapping of a recombinant chimeric monoclonal antibody and method validation challenges. , 1997, Journal of pharmaceutical and biomedical analysis.

[6]  M. Mann,et al.  Automation of micro‐preparation and enzymatic cleavage of gel electrophoretically separated proteins , 1995, FEBS letters.

[7]  Hongcheng Liu,et al.  Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  D. Fenyö,et al.  Reproducibility of LC-MS-based protein identification. , 2006, Journal of experimental botany.

[9]  D. Fenyö,et al.  Detection of artifacts and peptide modifications in liquid chromatography/mass spectrometry data using two-dimensional signal intensity map data visualization. , 2006, Rapid communications in mass spectrometry : RCM.

[10]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[11]  A. Podtelejnikov,et al.  Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Rahul S Rajan,et al.  Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. , 2006, Analytical chemistry.

[13]  D. Chelius,et al.  Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. , 2002, Analytical chemistry.

[14]  Douglas S Rehder,et al.  Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies. , 2005, Analytical chemistry.

[15]  Douglas S Rehder,et al.  Reversed-phase liquid chromatography/mass spectrometry analysis of reduced monoclonal antibodies in pharmaceutics. , 2006, Journal of chromatography. A.

[16]  J. M. Beals,et al.  In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. , 2005, Analytical chemistry.

[17]  George M. Hilliard,et al.  Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times? , 2000, Journal of pharmaceutical and biomedical analysis.

[18]  Matthias Mann,et al.  Automated Protein Preparation Techniques Using a Digest Robot , 1997, Journal of protein chemistry.

[19]  D. Chelius,et al.  Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. , 2002, Journal of proteome research.

[20]  Zhongqi Zhang,et al.  De novo peptide sequencing based on a divide-and-conquer algorithm and peptide tandem spectrum simulation. , 2004, Analytical chemistry.

[21]  A. Plückthun,et al.  Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool. , 2001, Journal of molecular biology.

[22]  C. Watanabe,et al.  Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.